Complications of polyacrylamide gel filler in the Asian-Australian population A case series and literature review

Main Article Content

Amanda Yang Shen
Frank Lin

Keywords

breast, dermal fillers, injectables, foreign-body reaction, infection

Abstract

Polyacrylamide gel (PAAG), known as Aquamid® (Contura Limited, London, United Kingdom, EC4A 1LB) in Australia, is a hydrophilic, non-toxic substance introduced in the 1970s as a soft tissue filler. Banned in the late 1990s due to concerns regarding side effects such as breast cancer and glandular atrophy, there is currently no published data regarding PAAG fillers in the Australian literature. Given the increasing population of Chinese immigrants to Australia, complications will likely be seen more frequently within our healthcare system in the coming decades. This case series highlights two case in Australia with discussion of symptoms, signs and best-practice management.

Downloads

Download data is not yet available.
Abstract 80 | PDF Downloads 8 HTML Downloads 13

References

1. Chen L, Sha L, Huang S, Li S. Treatment for displacement of PAAG mixture after injection augmentation mammoplasty. Int J Clin Exp Med. 2015;8(3):3360-370. PMid:26064226 PMCid:PMC4443060
2. Chen B, Song H. Management of breast deformity after removal of injectable polyacrylamide hydrogel: retrospective study of 200 cases for 7 years. Aesthet Plast Surg. 2016;40(4):482-91. https://doi.org/10.1007/s00266-016-0646-5 PMid:27251750
3. Margolis N, Bassiri-Tehrani B, Chhor C, Singer C, Hernandez O, Moy L. Polyacrylamide gel breast augmentation: report of two cases and review of the literature. Clinl Imag. 2015;39(3):339-343. https://doi.org/10.1016/j.clinimag.2014.12.008 PMid:25670236
4. Zhao Y, Yuan N, Li K, Geng Y, Zhou H, Wang H, Hou J, Zhang B, Cai Y, ZhaoX. Bilateral breast cancer following augmentation mammaplasty with polyacrylamide hydrogel injection: a case report. Oncol Lett. 2015;9(6):2687-693. https://doi.org/10.3892/ol.2015.3116 PMid:26137129 PMCid:PMC4473364
5. Kalantar-Hormozi A, Mozafari N, Rasti M. Adverse effects after use of polyacrylamide gel as a facial soft tissue filler. Aesthe Surg J. 2008;28(2):139-42. https://doi.org/10.1016/j.asj.2007.12.005 PMid:19083518
6. Department of Home Affairs. Migration programme statistics 2018[Internet]. Canberra: Commonwealth of Australia [cited 24 January 2018]. Available from: https://archive. homeaffairs.gov.au/about/reports-publications/research-statistics/statistics/live-in-australia/migration-programme
7. Cheng N, Liu L, Hui L, Chen Y, Xu S. breast cancer following augmentation mammaplasty with polyacrylamide hydrogel (PAAG) injection. Aesthet Plast Surg. 2009;33(4):563-69. https://doi.org/10.1007/s00266-008-9298-4 PMid:19156460
8. Christensen L, Breiting V, Bjarnsholt T, Eickhardt S, Høgdall E, Janssen M et al. Bacterial infection as a likely cause of adverse reactions to polyacrylamide hydrogel fillers in cosmetic surgery. Clin Infect Diss. 2013;56(10):1438-444. https://doi.org/10.1093/cid/cit067 PMid:23392390
9. Patlazhan G, Unukovych D, Pshenisnov K. Breast reconstruction and treatment algorithm for patients with complications after polyacrylamide gel injections: a 10-year experience. Aesthet Plast Surg. 2013;37(2):312-20. https://doi.org/10.1007/s00266-012-0045-5 PMid:23381651
10. De Boulle K. Management of complications after implantation of fillers. J Cosmet Dermatol. 2004;3(1):2-15. https://doi.org/10.1111/j.1473-2130.2004.00058.x PMid:17163941
11. Jin R, Luo X, Wang X, Ma J, Liu F, Yang Q, Wang X. Complications and treatment strategy after breast augmentation by polyacrylamide hydrogel injection: summary of 10-year clinical experience. Aesthet Plast Surg. 2018 Apr;42(2):402-09. Epub 2017 Nov 9. https://doi.org/10.1007/s00266-017-1006-9 PMid:29124374
12. Luo S, Chen G, Sun Z, Cheng N. Our strategy in complication management of augmentation mammaplasty with polyacrylamide hydrogel injection in 235 patients. J Plast Reconst Aes. 2011;64(6):731-37. https://doi.org/10.1016/j.bjps.2010.10.004 PMid:21074506
13. Qiao Q, Wang X, Sun J, Zhao R, Liu Z, Wang Y, Sun B, Yan Y, Qi K.. Management for postoperative complications of breast augmentation by injected polyacrylamide hydrogel. Aesthet Plast Surg. 2005;29(3):156-61. https://doi.org/10.1007/s00266-004-0099-0 PMid:15948018
14. Chen L, Sha L, Huang S, Li S. Treatment for displacement of PAAG mixture after injection augmentation mammoplasty. Int J Clin Exp Med. 2015;8(3):3360-370. PMid:26064226 PMCid:PMC4443060
15. Kavoussi H, Ebrahimi A. Delayed Gel indurations as an adverse effect of polyacrylamide filler and its easy treatment. Dermatol Res Pract. 2012;2012:1-4. https://doi.org/10.1155/2012/539153 PMid:23093956 PMCid:PMC3474229
16. Radmanesh M, Radmanesh R, Bahadoram M. Successful removal of polyacrylamide hydrogel by pulsed fiberoptic 1444-nm Nd-YAG laser. J Cosmet Laser Ther. 2013;15(6):342-44. https://doi.org/10.3109/14764172.2013.807113 PMid:23692515
17. Ono S, Ogawa R, Hyakusoku H. Complications after polyacrylamide hydrogel injection for soft-tissue augmentation. Plast Reconstr Surg. 2010;126(4):1349-357. https://doi.org/10.1097/PRS.0b013e3181ead122 PMid:20885258